Archives of Medical Research
Volume 41, Issue 1 , Pages 1-6 , January 2010

Analysis of DNA Methylation Status of the Promoter of Human Telomerase Reverse Transcriptase in Gastric Carcinogenesis

  • Zhenghui Wang

      Affiliations

    • Department of Biochemistry, Tianjin Medical University, Tianjin, China
    • These authors contributed equally to this work.
    • ,
  • Jinheng Xu

      Affiliations

    • Tangshan Gongren Hospital of HeBei Meidical University, Tangshan, China
    • These authors contributed equally to this work.
    • ,
  • Xin Geng

      Affiliations

    • Department of Biochemistry, Tianjin Medical University, Tianjin, China
    • These authors are co-corresponding authors.
    • Corresponding Author InformationAddress reprint requests to: Xin Geng and Weiming Zhang, Department of Biochemistry, Tianjin Medical University, Tianjin, 300070 China; Phone: 0086-22-23542776 Fax: 0086-22-23542776
    • ,
  • Weiming Zhang

      Affiliations

    • Department of Biochemistry, Tianjin Medical University, Tianjin, China
    • These authors are co-corresponding authors.
    • Corresponding Author InformationAddress reprint requests to: Xin Geng and Weiming Zhang, Department of Biochemistry, Tianjin Medical University, Tianjin, 300070 China; Phone: 0086-22-23542776 Fax: 0086-22-23542776

Received 2 August 2009 ,Accepted 12 October 2009.

References 

  1. Tan YK, Fielding JW. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006;18:821–829
  2. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168
  3. Lambert MP, Herceg Z. Epigenetics and Cancer, 2nd IARC Meeting. Lyon, France, 6 and 7 December 2007 Mol Oncol. 2008;2:33–40
  4. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245–254
  5. Choi IS, Wu TT. Epigenetic alterations in gastric carcinogenesis. Cell Res. 2005;15:247
  6. Nomoto K, Maekawa M, Sugano K, et al. Methylation status and expression of human telomerase reverse transcription mRNA in relation to hypermethylation of p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Jpn J Clin Oncol. 2002;32:3–8
  7. Berletch JB, Liu C, Love WK, et al. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem. 2008;103:509–519
  8. Shen L, Kondo Y, Guo Y, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 2007;3:2023
  9. Guilleret I, Benhattar J. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem Biophys Res Commun. 2004;325:1037–1043
  10. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2:S24
  11. Zinn RL, Pruitt K, Eguchi S, et al. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 2007;67:194
  12. Fleisher AS, Esteller M, Wang S, Tamura G, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999;59:1090–1095
  13. Carvalho B, Pinto M, Cimes L, et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer. 2003;39:1222–1227
  14. Hong SH, Kim HG, Chung WB, et al. DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci. 2005;20:236–241
  15. Lee S, Lee HJ, Kim HJ, et al. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol. 2003;163:1371–1378
  16. Devereux TR, Horikawa I, Anna CH, et al. DNA methylation analysis of promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res. 1999;59:6087
  17. Dessain SK, Yu H, Reddel RR, et al. Methylation of the human telomerase gene CpG island. Cancer Res. 2000;60:537–541
  18. Guilleret I, Yan P, Grange F, et al. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer. 2002;101:335–341
  19. Perini G, Diolaiti D, Porro A, et al. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA. 2005;102:12117–12122
  20. Campanero MR, Armstrong MI, Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci USA. 2000;97:6481–6486
  21. Cemi C. Telomeres, telomerase and myc. An update. Mutat Res. 2000;462:31
  22. Zou L, Zhang P, Tu Z. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase and telomerase activity. Urology. 2006;67:1335–1340
  23. Jie L, Mao DL. DNA methylation, histone deacetylation and suppression of gene expression. Chin J Clin Exp Pathol. 2006;22:353–370

PII: S0188-4409(09)00202-1

doi: 10.1016/j.arcmed.2009.11.001

Archives of Medical Research
Volume 41, Issue 1 , Pages 1-6 , January 2010

Article Tools

* Image Usage & Resolution